Researchers sought to determine the effect of changes in screening guidelines on incidence of breast cancer by stage at diagnosis and surgical management.

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

Treatment for breast cancer may take many forms ... According to ACS, women at average risk should follow these guidelines: ...

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

One in eight women will suffer from breast cancer in their lifetime. Eight percent will decline treatment due to the fear of alopecia. Regular physical activity prior to a cancer diagnosis lowered ...

The incidence of in situ breast cancer has decreased since 2009, consistent with decreasing use of mammography in association ...

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

Cerca Biotech's innovative breast cancer molecular subtyping assay is recognized by leading professional associations in China BERLIN, GE ...

AI-supported mammography screening significantly increases breast cancer detection rates while maintaining comparable recall ...